Business Wire | October 20, 2017
Vyaire Medical, Inc., the healthcare industry’s dedicated “breathing company,” today announced it has acquired Revolutionary Medical Devices, Inc. (RMD), of Tucson, Ariz., a maker of innovative products for airway management, focused on significantly improving patient outcomes.
RMD’s main product, the SuperNO2VA™ is a complete noninvasive nasal PAP ventilation system designed for use in the treatment of respiratory insufficiency from collapse of the airway during or after sedation, or during the intubation process. The SuperNO2VA system effectively opens the upper airway, maintains patency, and allows the anesthesiologist to effectively ventilate the patient. It is designed to reduce the likelihood of respiratory compromise via perioperative hypoxemia, particularly with “high risk” patients who may present with difficult airways.
“The acquisition of Revolutionary Medical Devices allows Vyaire to bring another clinically-differentiated airway management solution to the medical device marketplace,” said Dave Mowry, Vyaire’s President and Chief Executive Officer. “RMD’s SuperNO2VA nasal PAP ventilation system enables anesthesiologists to provide oxygen to sedated patients in a more controlled and noninvasive way, and is exactly the type of unique and thoughtfully-designed product we want to bring to our customers.”